Mechanistic Study of Xanthohumol Against Rheumatoid Arthritis via Regulation of p38/MAPK Pathway

To elucidate the molecular mechanism by which xanthohumol (XN) alleviates rheumatoid arthritis (RA), this study integrated network pharmacology prediction, proteomic screening, and molecular dynamics simulation to systematically evaluate the inhibitory effects and targets of XN in TNF-α-induced fibroblast-like synoviocytes (MH7A cells). XN dose-dependently reversed the pathological proliferation and invasive behavior of MH7A cells and down-regulated pro-inflammatory cytokines such as IL-1β and IL-6, as well as fibrosis/angiogenesis-related factors including TGF-β1 and VEGF. Cross-validation of network pharmacology and proteomics indicated that these effects were closely associated with the inhibition of the p38/MAPK pathway, modulating inflammatory signal transduction to exert anti-RA effects. Molecular docking revealed that XN bound to the ATP-binding pocket of p38α kinase with an optimal binding energy of −7.623 kcal/mol, forming a stable hydrogen-bond network and hydrophobic stacking with the P-loop, hinge region, and catalytic residue Lys53. Molecular dynamics simulation (100 ns) combined with MM/GBSA analysis (ΔGbind = −104.14 kcal/mol) showed that the complex conformation was highly convergent, with significantly reduced RMSF of key residues in the catalytic domain, suggesting that XN induces rigidification of the kinase catalytic domain by stably occupying the ATP site, thereby blocking its phosphotransfer activity. Collectively, these results demonstrate that XN targets p38α kinase to inhibit the p38/MAPK pathway, intervening in RA pathological progression at multiple levels and providing experimental evidence for its anti-RA molecular mechanism.

Authors

Institutions

Publication Details

Journal
Molecules
Published
2026-11-19
DOI
https://doi.org/10.3390/molecules31224192
Primary Topic
Natural Compounds in Disease Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mechanistic Study of Xanthohumol Against Rheumatoid Arthritis via Regulation of p38/MAPK Pathway

Ke Fu, Huayong Peng, Jin Wang, Depo Yang et al.
Molecules
Natural Compounds in Disease Treatment
article

Mechanistic Study of Xanthohumol Against Rheumatoid Arthritis via Regulation of p38/MAPK Pathway

Ke Fu, Huayong Peng, Jin Wang, Depo Yang, Jianchao Wang, Lanting Zhou, Hai Li, Xiuye Ma
article en

Abstract

To elucidate the molecular mechanism by which xanthohumol (XN) alleviates rheumatoid arthritis (RA), this study integrated network pharmacology prediction, proteomic screening, and molecular dynamics simulation to systematically evaluate the inhibitory effects and targets of XN in TNF-α-induced fibroblast-like synoviocytes (MH7A cells). XN dose-dependently reversed the pathological proliferation and invasive behavior of MH7A cells and down-regulated pro-inflammatory cytokines such as IL-1β and IL-6, as well as fibrosis/angiogenesis-related factors including TGF-β1 and VEGF. Cross-validation of network pharmacology and proteomics indicated that these effects were closely associated with the inhibition of the p38/MAPK pathway, modulating inflammatory signal transduction to exert anti-RA effects. Molecular docking revealed that XN bound to the ATP-binding pocket of p38α kinase with an optimal binding energy of −7.623 kcal/mol, forming a stable hydrogen-bond network and hydrophobic stacking with the P-loop, hinge region, and catalytic residue Lys53. Molecular dynamics simulation (100 ns) combined with MM/GBSA analysis (ΔGbind = −104.14 kcal/mol) showed that the complex conformation was highly convergent, with significantly reduced RMSF of key residues in the catalytic domain, suggesting that XN induces rigidification of the kinase catalytic domain by stably occupying the ATP site, thereby blocking its phosphotransfer activity. Collectively, these results demonstrate that XN targets p38α kinase to inhibit the p38/MAPK pathway, intervening in RA pathological progression at multiple levels and providing experimental evidence for its anti-RA molecular mechanism.

MoleculesVol. 31(22)
Jishou University (CN), Sun Yat-sen University (CN)
Natural Compounds in Disease Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon